XML 47 R29.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2019
Stockholders' Equity Note [Abstract]  
Schedule of Fair Value of Warrants Based on the option pricing valuation model, the Company determined the fair value of the warrants as of the Closing Date to be the following:
(in thousands)
Warrants Liability
Series A Warrants
$
3,862

Series B-1 Warrants (1)
328

Series B-2 Warrants
376

Series C Warrants (2)
6,232

Total
$
10,798

1) Series B-1 warrants expired in January 2020.
2) Series C warrants were exercised in October 2019.
 

Schedule of Valuation Assumptions for Stock Options The fair value of options at date of grant was estimated using the Black-Scholes method utilizing the following assumptions:
Dividend yield
0.0%
Expected volatility
44.5
%
-
52.9%
Risk-free interest rate
1.3
%
-
2.7%
Expected life of options (in years)
5.21

-
10.00

Summary of Stock Options Activity
A summary of the options granted, exercised and expired during the years ended December 31, 2017, 2018 and 2019 is presented below:
 
 
Number of
shares
 
Weighted-Average
Exercise Price
Options outstanding as of December 31, 2016
 
3,445,512

 
$
30.65

Options expired
 
(1,260
)
 
20.24

Options outstanding as of December 31, 2017
 
3,444,252

 
30.65

Options exercised (1)
 
(347,752
)
 
15.45

Options expired
 
(2,050,587
)
 
39.74

Options outstanding as of December 31, 2018
 
1,045,913

 
17.89

Options granted
 
925,000

 
5.64

Options exercised
 
(68,259
)
 
17.44

Options forfeited
 
(363,687
)
 
15.15

Options outstanding as of December 31, 2019
 
1,538,967

 
$
11.27

Options exercisable as of December 31, 2019
 
765,217

 
$
17.04

(1) Includes 125,523 options withheld to pay the exercise price for certain exercises during the year ended December 31, 2018.
Options Outstanding Range of Exercise Prices
The following table summarizes information about options outstanding as of December 31, 2019:
 
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
 
Options Outstanding
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life (Years)
 
Options
Exercisable
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life (Years)
$1.88 - 5.38
 
635,000

 
$
3.57

 
9.84
 
81,250

 
$
2.57

 
9.70
$10.00 - $19.31
 
638,385

 
12.98

 
5.38
 
418,385

 
14.42

 
3.26
$20.11 - $25.86
 
259,525

 
25.22

 
1.15
 
259,525

 
25.22

 
1.15
$40.80
 
6,057

 
40.80

 
4.62
 
6,057

 
40.80

 
4.62
 
 
1,538,967

 
$
11.27

 
6.51
 
765,217

 
$
17.04

 
3.24

Unvested Stock Awards
A summary of the stock awards granted, vested and forfeited during the years ended December 31, 2017, 2018 and 2019 is presented as follows. RSU awards with undelivered shares are classified as unvested until the date of delivery of the shares.
Unvested Stock Awards
 
Restricted
Stock Awards
 
Restricted
Stock Units
 
Number of
Shares
Underlying
Awards
 
Weighted
Average
Grant-Date Fair Value
Unvested as of December 31, 2016
 
3,748

 
1,042,385

 
1,046,133

 
$
37.16

Vested
 
(1,623
)
 
(185,754
)
 
(187,377
)
 
36.45

Forfeited
 
—

 
(76,719
)
 
(76,719
)
 
38.48

Unvested as of December 31, 2017
 
2,125

 
779,912

 
782,037

 
$
37.22

Granted
 
—

 
2,872,408

 
2,872,408

 
22.53

Vested
 
(2,125
)
 
(2,077,253
)
 
(2,079,378
)
 
27.55

Forfeited
 
—

 
(108,932
)
 
(108,932
)
 
29.50

Unvested as of December 31, 2018
 
—

 
1,466,135

 
1,466,135

 
$
22.62

Granted
 
—

 
2,578,866

 
2,578,866

 
7.56

Vested
 
—

 
(854,998
)
 
(854,998
)
 
23.96

Forfeited
 
—

 
(529,767
)
 
(529,767
)
 
18.47

Unvested as of December 31, 2019
 
—

 
2,660,236

 
2,660,236

 
$
8.42